Mizuho rated Buy Healthsouth Corporation (NYSE: HLS) on 02/16/2012, when the stock price was $20.17. Since then, Healthsouth Corporation has gained 48.93% as of 05/24/2013's recent price of $30.04.
If you would have followed this Mizuho's recommendation on HLS, you would have gained 48.93% of your investment in 463 days.

HealthSouth Corporation (HealthSouth) is a provider of inpatient rehabilitative healthcare services. The Company operates 93 inpatient rehabilitation hospitals, six freestanding long-term acute care hospitals (LTCHs), 49 outpatient rehabilitation satellites (operated by its hospitals), and 25 licensed, hospital-based home health agencies. Its outpatient rehabilitation facilities offer a range of rehabilitative healthcare services, including physical, occupational and speech therapies treating a range of neurological and orthopedic conditions. LTCHs provide medical treatment to patients with chronic diseases and/or complex medical conditions. In August 2008, the Company acquired an inpatient rehabilitation unit at the Medical Center of Arlington in Texas. In August 2008, it acquired an inpatient rehabilitation hospital in Midland, Texas from Rehabcare Corporation. On July 31, 2008, it acquired The Rehabilitation Hospital of South Jersey.

Mizuho

Marked as spam